Public Firms Now Control 16% of Crypto Revenue as Traditional Finance Enters BlockchainOctober 30, 2026
Cybersecurity Firms Gain Three-Tier Access to Anthropic’s Claude Mythos and Latest ModelsOctober 7, 2026
How Professional Crypto Traders Use Multiple Exchanges to Arbitrage Execution, Not Just PriceJune 1, 2026
Public Firms Now Control 16% of Crypto Revenue as Traditional Finance Enters BlockchainOctober 30, 2026
Stock NUBURU, Inc. (BURU) stock: slides as company unveils portable laser counter-drone defense systemBy Yasmin WernerMarch 9, 2026
Stock Newmont (NEM) Stock Soars on Major Price Target Hikes from Top AnalystsBy Trader EdgeMarch 9, 2026
Stock Delta Air Lines (DAL) Stock Drops as TD Cowen Slashes Price Target Amid Fuel Cost WorriesBy Trader EdgeMarch 9, 2026
Stock BitMine (BMNR) Ramps Up Ethereum Accumulation as Chairman Signals Market BottomBy Trader EdgeMarch 9, 2026
Stock Apple (AAPL) Stock: Why Wall Street Remains Bullish Despite DRAM Price SurgeBy Trader EdgeMarch 9, 2026
iGaming Caesars Entertainment (CZR): Goldman Sachs Expands Position While Acquisition Odds Surge to 68%By Oliver DaleMarch 9, 2026
iGaming DraftKings Shares Tumble 45% Yet Wall Street Sees Nearly 50% Rebound AheadBy Oliver DaleMarch 9, 2026
Stock Autozi Internet (AZI) Stock Soars 108% on $110 Million Investment ProposalBy Trader EdgeMarch 9, 2026
Stock Unusual Machines (UMAC) Stock Surges 10% on Strong Revenue Performance in 2025By Trader EdgeMarch 9, 2026
Stock Ondas Holdings (ONDS) Stock Skyrockets After Mistral Inc. Defense Merger AgreementBy Trader EdgeMarch 9, 2026
Stock Nvidia (NVDA) Stock Drops 3% Amid Middle East Turmoil and Chip Supply ConcernsBy Trader EdgeMarch 9, 2026
Stock Crude Oil Surges Past $100 Amid Iran Crisis, Triggering Sharp Stock Market SelloffBy Trader EdgeMarch 9, 2026
Stock Microsoft (MSFT) Stock Drops 15% YTD as Copilot Cowork with Anthropic Claude DebutsBy Trader EdgeMarch 9, 2026
Stock uniQure (QURE) Stock Jumps 36% Following FDA Director Prasad’s Exit AnnouncementBy Trader EdgeMarch 9, 2026
Stock Xenon Pharmaceuticals (XENE) Stock Rockets 40% After Epilepsy Drug Trial Crushes GoalsBy Trader EdgeMarch 9, 2026
Stock Relmada Therapeutics (RLMD) Stock Jumps 31% on Promising Bladder Cancer DataBy Trader EdgeMarch 9, 2026
Stock Aureus Greenway (AUGS) Stock Jumps 55% Following Trump-Linked Drone Company Merger AnnouncementBy Trader EdgeMarch 9, 2026
